Workflow
Rockwell Medical (RMTI) Surpasses Q3 Earnings and Revenue Estimates
RMTIRockwell Medical(RMTI) ZACKS·2024-11-12 13:10

Core Viewpoint - Rockwell Medical reported quarterly earnings of 0.05pershare,significantlyexceedingtheZacksConsensusEstimateof0.05 per share, significantly exceeding the Zacks Consensus Estimate of 0.01 per share, and showing an improvement from a loss of 0.07pershareayearago[1][2].FinancialPerformance−Thecompanyachievedrevenuesof0.07 per share a year ago [1][2]. Financial Performance - The company achieved revenues of 28.32 million for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 8.95% and increasing from 23.77millioninthesamequarterlastyear[3].−Overthelastfourquarters,RockwellMedicalhasconsistentlyexceededconsensusEPSandrevenueestimates[2][3].StockPerformance−RockwellMedicalshareshaveincreasedapproximately14623.77 million in the same quarter last year [3]. - Over the last four quarters, Rockwell Medical has consistently exceeded consensus EPS and revenue estimates [2][3]. Stock Performance - Rockwell Medical shares have increased approximately 146% since the beginning of the year, outperforming the S&P 500's gain of 25.8% [4]. - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [7]. Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is 0.01 on revenues of 24.31million,whileforthecurrentfiscalyear,theestimateis−24.31 million, while for the current fiscal year, the estimate is -0.03 on revenues of $98.8 million [8]. - The trend of estimate revisions for Rockwell Medical is mixed, which may change following the recent earnings report [7]. Industry Context - The Medical - Products industry, to which Rockwell Medical belongs, is currently ranked in the top 34% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [9].